Results 141 to 150 of about 6,511 (194)

Real-life data on pasireotide in monotherapy or combined in active Cushing's disease. [PDF]

open access: yesFront Endocrinol (Lausanne)
Mondin A   +6 more
europepmc   +1 more source

Long-term primary pharmacotherapy of giant prolactinomas: A comparison of different cabergoline dosages. [PDF]

open access: yesJ Clin Transl Endocrinol
Václav H   +11 more
europepmc   +1 more source

Recurrent pituitary apoplexy: experience from a national registry and review of the literature. [PDF]

open access: yesTher Adv Endocrinol Metab
Biagetti B   +9 more
europepmc   +1 more source

Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas? [PDF]

open access: yesPituitary
Agrawal N   +11 more
europepmc   +1 more source

Effect of cabergoline on the management of diabetes mellitus: a systematic review and meta-analysis. [PDF]

open access: yesCardiovasc Diabetol Endocrinol Rep
Khorasani S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy